Fiche centre
Fondazione Policlinico Universitario A. Gemelli IRCCS
Roma — Italy
Essais liés3clinical trials
VilleRomalocalisation
PaysItalylocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT06551649
Essais cliniques associés
3| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| CONTRASTOME — Human Amniotic Mesenchymal Cell Secretome for Neurodegeneration and Neuroinflammation | Sclérose latérale amyotrophique | Non applicable | NCT06551649 | CONTRASTOME — Human Amniotic Mesenchymal Cell Secretome for Neurodegeneration and Neuroinflammation | ACTIVE_NOT_RECRUITING |
| Proteomic Changes in Patients With Myasthenia Gravis and Ravulizumab | Myasthénie | À vérifier | NCT07337395 | Proteomic Changes in Patients With Myasthenia Gravis and Ravulizumab | NOT_YET_RECRUITING |
| Sacituzumab govitecan-hziy | Cancer | Phase 3 | NCT06486441 | Study of Sacituzumab Govitecan Versus Treatment of Physician's Choice in Participants With Endometrial Cancer After Platinum-Based Chemotherapy and Immunotherapy (ASCENT-GYN-01/GOG-3104/ENGOT-en26) | ACTIVE_NOT_RECRUITING |